Toxicity

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE

CONTACT US TO ORDER

Zebrafish Metabolic Disruption Assay

Q: What types of compounds can be evaluated?

Our platform covers pharmaceuticals, industrial chemicals, pesticides, personal care ingredients, natural products, nanoparticles and environmental pollutants suspected to impair endocrine or metabolic function.

Q: What developmental stages of zebrafish are frequently used?

Most research are performed in embryos or larvae, which allows for rapid chemical exposure, fast phenotypic assessment and high-throughput analysis. Juvenile fish may also be utilized when the objectives of a particular investigation so dictate.

Q: Can the assay evaluate specific endocrine-mediated metabolic pathways?

Yeah. Study designs can be tailored to explore lipid metabolism, glucose homeostasis, energy balance, thyroid hormone-regulated pathways, insulin signaling, or other metabolism-related mechanisms with phenotypic, imaging, and molecular endpoints.

Q: Is molecular analysis available?

Yes. Optional downstream analysis include gene expression profiling, fluorescence reporter imaging, histopathology, whole mount staining and other mechanistic tests to enable pathway-level investigations.

Q: Could this assay be performed in combination with other endocrine toxicity studies?

Yes. The Metabolic Disruption Assay can be combined with other Zebrafish Endocrine & Metabolic Toxicity services, such as endocrine disruption, thyroid toxicity, developmental toxicity, hepatotoxicity, oxidative stress, and reproductive toxicity assessments, for a more comprehensive assessment of compound safety.

Overview Service Details Workflow Features FAQ

Overview

Metabolic homeostasis is tightly controlled by endocrine signaling networks that govern lipid metabolism, glucose utilization, energy balance and growth. Metabolism-disrupting chemicals (MDCs) that might interfere with these pathways may lead to metabolic dysfunction before over toxicity is apparent. Our Zebrafish Metabolic Disruption Assay is an in vivo platform for evaluation of endocrine-related metabolic disturbances using integrated phenotypic, physiological and molecular analysis, supporting pharmaceutical safety assessment, chemical screening and environmental toxicity studies.

Key Advantages

Whole-organism evaluation of endocrine-regulated metabolic homeostasis
Early identification of metabolism-disrupting chemicals (MDCs)
Simultaneous assessment of lipid, glucose, and energy metabolism
Compatible with acute, chronic, and developmental exposure designs
High-content fluorescence imaging and automated image analysis
Flexible assay customization for mechanistic or regulatory studies
Cost-effective alternative for early metabolic toxicity screening

Service Details

Our Metabolic Disruption Assay is designed to characterize compound-induced metabolic alterations associated with endocrine dysregulation using zebrafish embryos or larvae. Study designs are tailored according to compound properties, exposure duration, and research objectives.

Assessment of Energy Homeostasis

General metabolic status is evaluated through physiological and developmental indicators, including:

Body growth and developmental progression
Body length measurement
Yolk sac utilization
Nutritional status
Survival and general morphology

Lipid Metabolism Assessment

Disruption of lipid homeostasis is assessed using established staining and quantitative imaging approaches.

Typical endpoints include:

Whole-body lipid accumulation
Hepatic lipid deposition
Neutral lipid distribution
Lipid mobilization efficiency
Quantitative fluorescence or image-based lipid analysis

Glucose Metabolism Assessment

To evaluate endocrine-regulated glucose homeostasis, our assay may include:

Whole-body glucose utilization
Glycogen storage analysis
Energy metabolism assessment
Feeding-associated metabolic responses
Recovery following compound exposure

Liver-Associated Metabolic Evaluation

As the liver plays a central role in systemic metabolism, hepatic endpoints may include:

Liver morphology
Liver size measurement
Hepatic steatosis
Liver-specific fluorescent reporter analysis
Histopathological examination (optional)

Endpoints

Phenotypic Endpoints

Survival rate
Body length
Growth inhibition
Developmental abnormalities
General morphology
Behavioral observations (optional)

Metabolic Endpoints

Whole-body lipid accumulation
Hepatic steatosis
Liver morphology
Glucose homeostasis indicators
Glycogen storage
Energy metabolism parameters
Mitochondrial function biomarkers
Oxidative stress indicators
Expression of metabolism-related biomarkers

Workflow

Why Choose Us

Our standardized zebrafish platform provides reliable and quantitative assessment of endocrine-related metabolic toxicity.

Standardized Assays

Reproducible protocols for consistent metabolic toxicity evaluation.

Integrated Endpoints

Simultaneous assessment of lipid metabolism, glucose homeostasis, liver morphology, and growth.

Quantitative Analysis

High-content imaging combined with objective image-based data analysis.

Flexible Study Design

Customizable endpoints and optional molecular analyses to meet specific research objectives.

FAQ

What types of compounds can be evaluated?

What developmental stages of zebrafish are frequently used?

Can the assay evaluate specific endocrine‑mediated metabolic pathways?

Is molecular analysis available?

Could this assay be performed in combination with other endocrine toxicity studies?

For research use only. Not intended for any clinical use.